Next-Generation Sequencing in Thyroid Cancer

November 22, 2014
Marcia S. Brose, MD, PhD

Marcia S. Brose, MD, PhD, assistant professor, Abramson Cancer Center at the University of Pennsylvania, discusses next-generation sequencing in thyroid cancer.

Clinical Pearls

Marcia S. Brose, MD, PhD, assistant professor, Abramson Cancer Center at the University of Pennsylvania, discusses next-generation sequencing in thyroid cancer.

  • Data have been inconclusive regarding the appropriate use of next-generation sequencing in thyroid cancer.
  • Next-generation sequencing may help identify higher-risk patients.
  • In most patients, care is clear from their pathology.
  • There is clearly a role for next-generation sequencing in the advanced setting.